EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS182-13201 
Organism
Homo sapiens 
Tissue/cell
Spleen 
Coordinate
chr2:218705780-218707810 
TF binding sites/motifs
Number: 9             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
E2F6MA0471.1chr2:218705958-218705969GGGCGGGAAGC+6.02
EWSR1-FLI1MA0149.1chr2:218707308-218707326CTCTCCCTCCTTCCATCC-6.04
EWSR1-FLI1MA0149.1chr2:218706053-218706071GGAAGGAAGGGAGGATAT+6.44
EWSR1-FLI1MA0149.1chr2:218707312-218707330CCCTCCTTCCATCCTGCC-6.68
EWSR1-FLI1MA0149.1chr2:218706049-218706067GGCAGGAAGGAAGGGAGG+7.82
EWSR1-FLI1MA0149.1chr2:218706045-218706063GGGAGGCAGGAAGGAAGG+7.88
ZNF263MA0528.1chr2:218705891-218705912AAGGGAGAAGGGGGAAGGAGA+6.21
ZNF263MA0528.1chr2:218705800-218705821GAAGGAAGAAGGTGGGAAAGA+6.38
ZNF263MA0528.1chr2:218706047-218706068GAGGCAGGAAGGAAGGGAGGA+6.72
Number of super-enhancer constituents: 17             
IDCoordinateTissue/cell
SE_00005chr2:218676398-218731742Adipose_Nuclei
SE_00853chr2:218705769-218706772Adrenal_Gland
SE_01533chr2:218700407-218707915Aorta
SE_05795chr2:218700443-218707204Brain_Hippocampus_Middle
SE_26107chr2:218705844-218710641Duodenum_Smooth_Muscle
SE_26522chr2:218705745-218706920Esophagus
SE_29627chr2:218705362-218706516Fetal_Muscle
SE_36939chr2:218685985-218724919HSMMtube
SE_40583chr2:218693978-218725316Left_Ventricle
SE_42142chr2:218698721-218707980Lung
SE_46622chr2:218705860-218706478Ovary
SE_46622chr2:218706490-218706989Ovary
SE_48080chr2:218698688-218725214Psoas_Muscle
SE_48661chr2:218700415-218707894Right_Atrium
SE_51206chr2:218689199-218725234Skeletal_Muscle
SE_53299chr2:218700459-218707055Spleen
SE_54481chr2:218694206-218712678Stomach_Smooth_Muscle
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr2218706800218707458
Number: 2             
IDChromosomeStartEnd
GH02I217835chr2218699857218706417
GH02I217841chr2218706491218706989
Enhancer Sequence
AGAGGAAAAG ACAGAGGAGA GAAGGAAGAA GGTGGGAAAG ATTTGGAAGG AATAGCACAT 60
GAAGAAGGAG TGAAAAGAAA CTGATGCTCA AAAGTGGGCC AAAGAGCTGG AAAGGGAGAA 120
GGGGGAAGGA GAGCCACCCA CCAGAGAGGG AGGAAGATTG GAGCCGGTGG AGAGGAGGGG 180
GCGGGAAGCT GCCACTGTGT CCGATGCCCT GCAGCCTGGC GTTGTACGCT GCCCACCCCC 240
CACCCCAGGG GAGCCAGCAG GGAGTGGGAG GCAGGAAGGA AGGGAGGATA TGGGGCAAGG 300
CAGGCACCCC ACCAACAGCA CAGGGAACAG ATGGACATGG GAAACACAGA GAGTGCAGGG 360
GACGGGGCAT TAAACAGGAC AAAACACAAC AAAAACAAAG AGAAAATCAA GATTAGTTGG 420
TGTTCTGACT CTGGTATCTG GGCACACACT GGAGGGAGGT GGGGAAGGTA TCAGACAGGA 480
AGAGAGGGGG ATCCAAGGTC CTGCTTCTCC AAGAGGCAGA TGGACCTCCT GCTGGCCAGC 540
ACCACAGCGT TTCCCTCTCT TCTAACCCCA GGGTGGAAGC AGAGGTGCCA TCGTGGGACC 600
AGGAGAATTC ACGCATCCCT CACCTGCTCC CATAGGCAGC AGGCCTGTCC CTGGACCACC 660
CATCTTTTCC TGGGCACCTG CCTCTCCCTG GACCCAGGTA ACACACCCAG CCTGAGCCCA 720
AGGGTCACCC TCTCTCACAC CCTGGCTCCT TACCACAGCC ATCTGAGTGA TCCTCTTTCC 780
TGGGGAACCC CTTGTGCTTT TCTGCTCTGG CCCCCAGCTT CTGGTCATCA CCAGAAAAGT 840
CCTTAAGATG AACCTTCTCA GATGCACTAG AAGGACCTGC TATGTTATCC TTTCCTTGCC 900
CCTTGTTGAC TTCTAACCCA CCTTCACACC ACAGGGGCCA CAGGAGTGGC CAACATTGCC 960
CCTGCCCTGG CCCCCAGAGT TCAAGCTATG TTACCTTTCC TCTCCTTCAC AAGCTGCTCC 1020
ATGCCAGTTC CTATGCTGGT TCCCTCCTCC TGTCTGTAGC CTTGGAATGT GGGAGGTTCC 1080
AGGACTCCAT CCTTGGGACC TCTCCTTACC TGTCCTCAAC CCCTCGGTGA CATTGCCCAG 1140
TGCTATGCTT AATCTGGTAT GTACACGTCA ACAATTCCCA TATCTCTAAG TTCCAGCCTC 1200
TTCTCCTTAA ACTCCTGACT CATTTATCCA ACCACTGCAG ATGTTTCATG GTCATCTCAA 1260
ACTTAATGTG TCCAAAAGTC ATGTTTCTAG TGTTCCCCTG AAACTGCTCT TCATAAATTG 1320
TTACCCATCT CAATAAAGAG CAACTCCATT CTTTAGTTGC TCAGGCCCCA GACCTAAGCG 1380
TTGTCTCTGA CTTTTCTCTT TCTCTCTCAT TCCATGTGTA ATCTATCAGT AATCTTGTTG 1440
GCTCTACCTC CAAAATATGT CTAAAATCCG AGCACTTCTC CCCTTTCCAT GGCCACTGCC 1500
CAGATCAATA GCAGCAGCCA CCTAACTGCT CTCCCTCCTT CCATCCTGCC CACCCTGGTC 1560
AATTCAGAAC AAGTCAGATG ATGTCACTCT TGGGCCCAAA TCCTTCCTAA GGCTTCTCAT 1620
GCCACACGGA GTAAAAGCCA CCATTCTTAC AATCACCTCA AAGACCCTCT GTAAGCTGTC 1680
CCTGTTCCCA TTTCCTCTCT GAACTTGTGT CCTGCTATGC CTCCCTTGAT CACTCTACTC 1740
CAGCCATGCC AGGCACACTC CTGCCTCGGG GCCTCTGCAC TTGTTGCTCC ATGGGGCTCA 1800
TCTCTCGCTG CCCAGCCCTG ATCATCCCAT GTAAAGTGCA GCCAGCCACC CCCTACCTCT 1860
CACTGCTTTA TCTCAATGGC ACGTATCACC TATCTGACAT ATCCTATGTA TATGTGCTTA 1920
TTTGCTCAGT ATCCATCTCT GCTGTAAGGG CAAGGATCTT TATTTGCCAC CATTTTCACA 1980
AAGCCTAGAC TGGCAAGCAG CACCCATTAG AAGTTCATGT TGAATCGAAT 2030